Exparel 1.3% 20ML 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTKP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,546
Award facts
- Contract value 100% obligated
- $19,545.68 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,545.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 1.3% in 20ML quantities (10 units). The award, issued on January 13, 2026, carries an ultimate completion date of January 13, 2026, with performance to be completed at the vendor's location in Park Ridge, Illinois. This delivery order was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. No subcontractor relationships were identified in the award documentation.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded in November 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, with a structure of one 30-month base period and three 30-month option periods. EXPAREL, a specialty surgical anesthetic product, exemplifies the broad range of pharmaceuticals—from routine medications to specialty biologics and oncology treatments—that DMS Pharmaceutical Group supplies through this strategic vendor arrangement to support military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTKP?
SPE2DR26FBTKP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FBTKP worth?
The government has obligated $19,546 on SPE2DR26FBTKP.
Is contract SPE2DR26FBTKP an order under another contract?
Yes. SPE2DR26FBTKP is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTKP competed?
The extent of competition for SPE2DR26FBTKP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award